What is included with this book?
Katherine Schneider received her Master's Degree in Public Health from Yale University School of Medicine in 1986 and was certified as a genetic counselor by the American Board of Medical Genetics in 1987. She has almost 20 years' experience as a genetic counselor and has been a cancer genetic counselor for the past 13 years. She is currently the Senior Genetic Counselor at the Dana-Farber Cancer Institute in Boston, MA, which has active high risk clinics and predictive testing programs.
Foreword | p. xi |
Preface | p. xiii |
Acknowledgments | p. xv |
Cancer Epidemiology | p. 1 |
Cancer Statistics | p. 1 |
Cancer Etiology | p. 10 |
Case Examples | p. 18 |
Further Reading | p. 21 |
Cancer Detection and Treatment | p. 23 |
The Diagnosis of Cancer | p. 23 |
Tumor Classification | p. 31 |
Cancer Treatment | p. 37 |
Further Reading | p. 45 |
Cancer Biology | p. 47 |
The Malignant Cell | p. 47 |
Carcinogenesis | p. 52 |
Oncogenes | p. 59 |
Tumor Suppressor Genes | p. 64 |
Epigenetic Mechanisms | p. 70 |
Further Reading | p. 73 |
Hereditary Cancer Syndromes | p. 75 |
Ataxia Telangiectasia | p. 75 |
Autoimmune Lymphoproliferative Syndrome (Also Canale-Smith Syndrome) | p. 77 |
Beckwith-Wiedemann Syndrome (Also Exomphalos Macroglossia Gigantism [EMG] Syndrome) | p. 78 |
Birt-Hogg-Dubé Syndrome | p. 80 |
Bloom Syndrome | p. 82 |
Blue Rubber Bleb Nevus Syndrome (Also Termed Bean Syndrome) | p. 83 |
Breast-Ovarian Cancer Syndrome, Hereditary | p. 84 |
Carney Complex, Types I and II (Includes NAME Syndrome and LAMB Syndrome) | p. 87 |
Diamond-Blackfan Anemia | p. 89 |
Familial Adenomatous Polyposis (Also Attenuated FAP, Gardner's Syndrome, Turcot Syndrome, and Hereditary Desmoid Disease) | p. 90 |
Fanconi Anemia | p. 93 |
Gastric Cancer, Hereditary Diffuse | p. 95 |
Gastrointestinal Stromal Tumor, Familial (Also Multiple GI Autonomic Nerve Tumors) | p. 97 |
Juvenile Polyposis (Includes Hereditary Mixed Polyposis) | p. 98 |
Leiomyomatosis Renal Cell Cancer, Hereditary | p. 100 |
Li-Fraumeni Syndrome | p. 101 |
Lynch Syndrome (Also Termed HNPCC) | p. 105 |
Melanoma, Cutaneous Malignant (Includes Familial Atypical Mole-Malignant Melanoma Syndrome, Dysplastic Nevus Syndrome, and Melanoma-Astrocytoma Syndrome) | p. 109 |
Multiple Endocrine Neoplasia, Type 1 (Also Wermer Syndrome) | p. 111 |
Multiple Endocrine Neoplasia, Type 2 (Also Sipple Syndrome, Familial Medullary Thyroid Carcinoma Syndrome) | p. 113 |
MYH-Associated Polyposis | p. 115 |
Neuroblastoma, Familial | p. 116 |
Neurofibromatosis, Type 1 (Also von Recklinghausen Disease) | p. 118 |
Neurofibromatosis, Type 2 | p. 119 |
Nevoid Basal Cell Carcinoma Syndrome (Also Gorlin Syndrome, Basal Cell Nevus Syndrome) | p. 121 |
Paraganglioma-Pheochromocytoma Syndrome, Hereditary (Including Carney-Stratakis Syndrome) | p. 123 |
Peutz-Jeghers Syndrome | p. 125 |
PTEN Hamartoma Syndrome (PHS) (Also Cowden Syndrome; Includes Bannayan-Riley-Ruvalcaba Syndrome and Proteus Syndrome) | p. 127 |
Renal Cell Carcinoma, Hereditary Papillary | p. 130 |
Retinoblastoma, Hereditary | p. 131 |
Rothmund-Thomson Syndrome | p. 133 |
Tuberous Sclerosis Complex (TSC) | p. 134 |
Von Hippel Lindau Syndrome | p. 137 |
Werner Syndrome (Also Termed Progeria of the Adult) | p. 139 |
Wilms Tumor, Familial (Includes Denys-Drash Syndrome, Frasier Syndrome, WAGR Syndrome) | p. 141 |
Xeroderma Pigmentosum (Includes XP/CS Complex, XP Variant) | p. 143 |
Further Reading | p. 145 |
All About Breast Cancer | p. 151 |
Overview of Breast Cancer | p. 151 |
Breast Cancer Management: Screening, Diagnosis, and Treatment | p. 162 |
Breast Cancer Syndromes | p. 171 |
Further Reading | p. 184 |
All About Colorectal Cancer | p. 187 |
Overview of Colorectal Cancer | p. 187 |
CRC Management: Screening, Diagnosis, and Treatment | p. 199 |
CRC Syndromes | p. 207 |
Further Reading | p. 218 |
Collecting and Interpreting Cancer Histories | p. 221 |
Collecting a Cancer History | p. 221 |
Challenges to Collecting an Accurate History | p. 242 |
Interpreting a Cancer History | p. 246 |
Case Examples | p. 255 |
Further Reading | p. 266 |
Cancer Risk Communication | p. 267 |
Genetic Counseling and Risk Perception | p. 267 |
The Communication of Risk | p. 278 |
Counseling Clients at various Risks | p. 289 |
Case Examples | p. 298 |
Further Reading | p. 306 |
Genetic Testing and Counseling | p. 309 |
The Logistics of Arranging Tests | p. 309 |
Pretest Counseling | p. 325 |
Results Disclosure and Follow-Up | p. 337 |
Case Examples | p. 346 |
Further Reading | p. 356 |
Psychosocial Aspects of Cancer Counseling | p. 357 |
The Psychosocial Features of Clients | p. 357 |
Making a Psychosocial Assessment | p. 379 |
Providing Additional Emotional Support | p. 394 |
Case Examples | p. 400 |
Further Reading | p. 407 |
Ethical Issues in Cancer Genetic Counseling | p. 409 |
Bioethical Principles and Guidelines | p. 409 |
Strategies for Resolving Ethical Dilemmas | p. 423 |
Types of Ethical Dilemmas in Cancer Genetic Counseling | p. 431 |
Issues of Justice | p. 442 |
Further Reading | p. 443 |
Specific Tumor Types and Associated Syndromes | p. 445 |
Review of Basic Pedigree Symbols | p. 457 |
Index | p. 459 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.